These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 7870141

  • 1. Images in clinical medicine. Shock delivered by an implantable cardioverter-defibrillator in response to spontaneous ventricular fibrillation.
    Roelke M, O'Nunain SS.
    N Engl J Med; 1995 Mar 30; 332(13):860. PubMed ID: 7870141
    [No Abstract] [Full Text] [Related]

  • 2. Ventricular fibrillation initiated by an electrocution injury and terminated by an implantable cardioverter-defibrillator.
    Perret JN, Sanders TW, d'Autremont SB, Patrick HC.
    J La State Med Soc; 2009 Mar 30; 161(6):343-7. PubMed ID: 20108829
    [Abstract] [Full Text] [Related]

  • 3. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E, Cappelli S, Cappato R.
    Heart Rhythm; 2013 Dec 30; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract] [Full Text] [Related]

  • 4. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH, Yee R, Jung W.
    J Am Coll Cardiol; 1996 Aug 30; 28(2):400-10. PubMed ID: 8800117
    [Abstract] [Full Text] [Related]

  • 5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 6. [Automatic implantable cardioverter-defibrillators in treating life-threatening ventricular tachyarrhythmias].
    Bodar' VI, Razymovskii VA, Belokon' NS.
    Klin Med (Mosk); 1996 May 08; 74(7):58-9. PubMed ID: 8992121
    [No Abstract] [Full Text] [Related]

  • 7. [Automated implantable cardioverter/defibrillators. Indications for implantation and clinical results].
    Ulbricht LJ, Emmerich K, Probst H, Krakau I, Gülker H.
    Z Kardiol; 1995 May 08; 84 Suppl 2():127-36. PubMed ID: 7571776
    [Abstract] [Full Text] [Related]

  • 8. Implantable cardioverter-defibrillator: present and future indications.
    Block M, Scheld H, Breithardt G.
    Arch Mal Coeur Vaiss; 1996 Feb 08; 89 Spec No 1():141-7. PubMed ID: 8734176
    [Abstract] [Full Text] [Related]

  • 9. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T, Luhmer I, Trappe HJ, Klein H, Fieguth HG, Brauer C, Scharpwinkel U, Kallfelz HC.
    Z Kardiol; 1993 Aug 08; 82(8):466-73. PubMed ID: 8212779
    [Abstract] [Full Text] [Related]

  • 10. Prevention of recurrent ventricular fibrillation by ventricular rate stabilization.
    Grimm W, Hoffmann J, Menz V, Maisch B.
    Europace; 2000 Oct 08; 2(4):346-9. PubMed ID: 11194604
    [Abstract] [Full Text] [Related]

  • 11. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M, Gurevitz OT, Trusty JM, Sharma V, Luria DM, Eldar M, Shen WK, Rea RF, Hammill SC, Friedman PA.
    Am J Cardiol; 2004 Dec 01; 94(11):1445-9. PubMed ID: 15566924
    [Abstract] [Full Text] [Related]

  • 12. Implantable cardioverter defibrillators save lives from lightning-related electrocution too!
    Kondur AK, Afonso LC, Berenbom LD, Lakkireddy DR.
    Pacing Clin Electrophysiol; 2008 Feb 01; 31(2):256-7. PubMed ID: 18233984
    [Abstract] [Full Text] [Related]

  • 13. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J, Schneider MA, Kuck KH.
    Z Kardiol; 1993 Nov 01; 82(11):683-91. PubMed ID: 8291289
    [Abstract] [Full Text] [Related]

  • 14. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ, Chang-Sing P, Flynn E, Martinez L, Peterson J, Ottoboni LK, Liem LB, Sung RJ.
    Circulation; 1995 Nov 01; 92(9):2558-64. PubMed ID: 7586357
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of ventricular tachyarrhythmias with an implantable pacemaker-cardioverter-defibrillator].
    Ohm OJ, Faerestrand S, Engedal H, Hegbom F, Stangeland L, Hoff PI.
    Tidsskr Nor Laegeforen; 1993 Jan 20; 113(2):182-9. PubMed ID: 8430397
    [Abstract] [Full Text] [Related]

  • 16. Inappropriate detection in an implantable cardioverter defibrillator after generator change.
    Narayanan K, Sharifzadehgan A, Juin C, Amet D, Swerdlow CD, Marijon E.
    Pacing Clin Electrophysiol; 2019 Jun 20; 42(6):736-738. PubMed ID: 30874319
    [No Abstract] [Full Text] [Related]

  • 17. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S, Tullo NG, Krol RB, Mauro AM.
    Arch Intern Med; 1989 Oct 20; 149(10):2333-9. PubMed ID: 2802898
    [Abstract] [Full Text] [Related]

  • 18. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL, Pogo GJ, Goldner BG, Kalenderian D, Merkatz K, Cohen MB, Snow JS, Cohen TJ.
    J Invasive Cardiol; 1995 Apr 20; 7(3):72-9. PubMed ID: 10155366
    [Abstract] [Full Text] [Related]

  • 19. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J, Huth C, Friedl A, Reinisch P, Pitschner HF, Schlepper M.
    Z Kardiol; 1993 Feb 20; 82(2):99-107. PubMed ID: 8465572
    [Abstract] [Full Text] [Related]

  • 20. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar 20; 1(1):43-7, AXIV. PubMed ID: 12132492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.